{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:34:48Z","timestamp":1754163288742,"version":"3.41.2"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T00:00:00Z","timestamp":1753488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["Nos. 91959114"],"award-info":[{"award-number":["Nos. 91959114"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-10798-1","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T12:51:17Z","timestamp":1753534277000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mitophagy related gene signature for prognosis and therapeutic evaluation in KIRC"],"prefix":"10.1038","volume":"15","author":[{"given":"Dengyi","family":"Duan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianmin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoping","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanjie","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,26]]},"reference":[{"key":"10798_CR1","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","volume":"404","author":"M Young","year":"2024","unstructured":"Young, M. et al. Renal cell carcinoma. Lancet 404, 476\u2013491. https:\/\/doi.org\/10.1016\/S0140-6736(24)00917-6 (2024).","journal-title":"Lancet"},{"key":"10798_CR2","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose, T. L. & Kim, W. Y. Renal cell carcinoma: A review. JAMA 332, 1001\u20131010. https:\/\/doi.org\/10.1001\/jama.2024.12848 (2024).","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10798_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000474531","volume":"31","author":"AV Bono","year":"1997","unstructured":"Bono, A. V. & Lovisolo, J. A. Renal cell carcinoma\u2013diagnosis and treatment: state of the Art. Eur. Urol. 31 (Suppl 1), 47\u201355. https:\/\/doi.org\/10.1159\/000474531 (1997).","journal-title":"Eur. Urol."},{"key":"10798_CR4","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.eururo.2022.01.040","volume":"81","author":"E Roussel","year":"2022","unstructured":"Roussel, E. et al. Novel imaging methods for renal mass characterization: A collaborative review. Eur. Urol. 81, 476\u2013488. https:\/\/doi.org\/10.1016\/j.eururo.2022.01.040 (2022).","journal-title":"Eur. Urol."},{"key":"10798_CR5","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.eururo.2015.12.004","volume":"69","author":"HS Andrade","year":"2016","unstructured":"Andrade, H. S. et al. Five-year oncologic outcomes after transperitoneal robotic partial nephrectomy for renal cell carcinoma. Eur. Urol. 69, 1149\u20131154. https:\/\/doi.org\/10.1016\/j.eururo.2015.12.004 (2016).","journal-title":"Eur. Urol."},{"key":"10798_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s13046-023-02742-w","volume":"42","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma. J. Exp. Clin. Cancer Res. 42, 159. https:\/\/doi.org\/10.1186\/s13046-023-02742-w (2023).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10798_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12943-023-01911-x","volume":"23","author":"Y Wang","year":"2024","unstructured":"Wang, Y. et al. Evolution of cell therapy for renal cell carcinoma. Mol. Cancer. 23, 8. https:\/\/doi.org\/10.1186\/s12943-023-01911-x (2024).","journal-title":"Mol. Cancer"},{"key":"10798_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/EDBK_280817","volume":"40","author":"JP Dutcher","year":"2020","unstructured":"Dutcher, J. P., Flippot, R., Fallah, J. & Escudier, B. On the shoulders of giants: the evolution of renal cell carcinoma Treatment-Cytokines, targeted therapy, and immunotherapy. Am. Soc. Clin. Oncol. Educ. Book. 40, 1\u201318. https:\/\/doi.org\/10.1200\/EDBK_280817 (2020).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book."},{"key":"10798_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1038\/s41392-023-01503-7","volume":"8","author":"S Wang","year":"2023","unstructured":"Wang, S. et al. The mitophagy pathway and its implications in human diseases. Signal. Transduct. Target. Ther. 8, 304. https:\/\/doi.org\/10.1038\/s41392-023-01503-7 (2023).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10798_CR10","doi-asserted-by":"publisher","first-page":"736","DOI":"10.7150\/thno.79876","volume":"13","author":"Y Lu","year":"2023","unstructured":"Lu, Y. et al. Cellular mitophagy: mechanism, roles in diseases and small molecule Pharmacological regulation. Theranostics 13, 736\u2013766. https:\/\/doi.org\/10.7150\/thno.79876 (2023).","journal-title":"Theranostics"},{"key":"10798_CR11","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/cdd.2012.81","volume":"20","author":"G Ashrafi","year":"2013","unstructured":"Ashrafi, G. & Schwarz, T. L. The pathways of mitophagy for quality control and clearance of mitochondria. Cell. Death Differ. 20, 31\u201342. https:\/\/doi.org\/10.1038\/cdd.2012.81 (2013).","journal-title":"Cell. Death Differ."},{"key":"10798_CR12","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.tplants.2018.02.010","volume":"23","author":"M Broda","year":"2018","unstructured":"Broda, M., Millar, A. H., Van Aken, O. & Mitophagy A mechanism for plant growth and survival. Trends Plant. Sci. 23, 434\u2013450. https:\/\/doi.org\/10.1016\/j.tplants.2018.02.010 (2018).","journal-title":"Trends Plant. Sci."},{"key":"10798_CR13","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca, A., Faitg, J., Auwerx, J. & Ferrucci, L. D\u2019Amico, D. Mitophagy in human health, ageing and disease. Nat. Metab. 5, 2047\u20132061. https:\/\/doi.org\/10.1038\/s42255-023-00930-8 (2023).","journal-title":"Nat. Metab."},{"key":"10798_CR14","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.molmed.2022.06.007","volume":"28","author":"A Ajoolabady","year":"2022","unstructured":"Ajoolabady, A., Chiong, M., Lavandero, S., Klionsky, D. J. & Ren, J. Mitophagy in cardiovascular diseases: molecular mechanisms, pathogenesis, and treatment. Trends Mol. Med. 28, 836\u2013849. https:\/\/doi.org\/10.1016\/j.molmed.2022.06.007 (2022).","journal-title":"Trends Mol. Med."},{"key":"10798_CR15","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1080\/15548627.2022.2139080","volume":"19","author":"R Han","year":"2023","unstructured":"Han, R., Liu, Y., Li, S., Li, X. J. & Yang, W. PINK1-PRKN mediated mitophagy: differences between in vitro and in vivo models. Autophagy 19, 1396\u20131405. https:\/\/doi.org\/10.1080\/15548627.2022.2139080 (2023).","journal-title":"Autophagy"},{"key":"10798_CR16","doi-asserted-by":"publisher","unstructured":"Dubrot, J. et al. In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma. Immunity 54, 571\u2013585 e576, https:\/\/doi.org\/10.1016\/j.immuni.2021.01.001 (2021).","DOI":"10.1016\/j.immuni.2021.01.001"},{"key":"10798_CR17","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1080\/15548627.2020.1831815","volume":"17","author":"B Wang","year":"2021","unstructured":"Wang, B. et al. PRCC-TFE3 fusion-mediated PRKN\/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma. Autophagy 17, 2475\u20132493. https:\/\/doi.org\/10.1080\/15548627.2020.1831815 (2021).","journal-title":"Autophagy"},{"key":"10798_CR18","doi-asserted-by":"publisher","first-page":"e14784","DOI":"10.7717\/peerj.14784","volume":"11","author":"S Ma","year":"2023","unstructured":"Ma, S. et al. A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma. PeerJ 11, e14784. https:\/\/doi.org\/10.7717\/peerj.14784 (2023).","journal-title":"PeerJ"},{"key":"10798_CR19","doi-asserted-by":"publisher","first-page":"1021690","DOI":"10.3389\/fcell.2022.1021690","volume":"10","author":"J Quan","year":"2022","unstructured":"Quan, J. & Huang, B. Identification and validation of the molecular subtype and prognostic signature for clear cell renal cell carcinoma based on neutrophil extracellular traps. Front. Cell. Dev. Biol. 10, 1021690. https:\/\/doi.org\/10.3389\/fcell.2022.1021690 (2022).","journal-title":"Front. Cell. Dev. Biol."},{"key":"10798_CR20","doi-asserted-by":"publisher","first-page":"1008714","DOI":"10.3389\/fonc.2022.1008714","volume":"12","author":"D Zheng","year":"2022","unstructured":"Zheng, D., Ning, J., Xia, Y., Ruan, Y. & Cheng, F. Comprehensive analysis of a homeobox family gene signature in clear cell renal cell carcinoma with regard to prognosis and immune significance. Front. Oncol. 12, 1008714. https:\/\/doi.org\/10.3389\/fonc.2022.1008714 (2022).","journal-title":"Front. Oncol."},{"key":"10798_CR21","doi-asserted-by":"publisher","unstructured":"Sayaman, R. W. et al. Germline genetic contribution to the immune landscape of cancer. Immunity 54, 367\u2013386 e368, https:\/\/doi.org\/10.1016\/j.immuni.2021.01.011 (2021).","DOI":"10.1016\/j.immuni.2021.01.011"},{"key":"10798_CR22","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1038\/s41588-023-01505-9","volume":"55","author":"W Lee","year":"2023","unstructured":"Lee, W. et al. Molecular basis for maternal inheritance of human mitochondrial DNA. Nat. Genet. 55, 1632\u20131639. https:\/\/doi.org\/10.1038\/s41588-023-01505-9 (2023).","journal-title":"Nat. Genet."},{"key":"10798_CR23","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/s41586-024-07340-0","volume":"629","author":"RZ Lin","year":"2024","unstructured":"Lin, R. Z. et al. Mitochondrial transfer mediates endothelial cell engraftment through mitophagy. Nature 629, 660\u2013668. https:\/\/doi.org\/10.1038\/s41586-024-07340-0 (2024).","journal-title":"Nature"},{"key":"10798_CR24","doi-asserted-by":"publisher","first-page":"13063","DOI":"10.1038\/s41598-024-63993-x","volume":"14","author":"Y Li","year":"2024","unstructured":"Li, Y. et al. Microbial metabolite sodium butyrate enhances the anti-tumor efficacy of 5-fluorouracil against colorectal cancer by modulating PINK1\/Parkin signaling and intestinal flora. Sci. Rep. 14, 13063. https:\/\/doi.org\/10.1038\/s41598-024-63993-x (2024).","journal-title":"Sci. Rep."},{"key":"10798_CR25","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1080\/15548627.2021.1985257","volume":"18","author":"P Ahuja","year":"2022","unstructured":"Ahuja, P. et al. Muscle-generated BDNF (brain derived neurotrophic factor) maintains mitochondrial quality control in female mice. Autophagy 18, 1367\u20131384. https:\/\/doi.org\/10.1080\/15548627.2021.1985257 (2022).","journal-title":"Autophagy"},{"key":"10798_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/15548627.2019.1628520","volume":"16","author":"C Yan","year":"2020","unstructured":"Yan, C. et al. PHB2 (prohibitin 2) promotes PINK1-PRKN\/Parkin-dependent mitophagy by the PARL-PGAM5-PINK1 axis. Autophagy 16, 419\u2013434. https:\/\/doi.org\/10.1080\/15548627.2019.1628520 (2020).","journal-title":"Autophagy"},{"key":"10798_CR27","doi-asserted-by":"publisher","unstructured":"Arcos, M. et al. PINK1-deficiency facilitates mitochondrial iron accumulation and colon tumorigenesis. Autophagy 1\u201317. https:\/\/doi.org\/10.1080\/15548627.2024.2425594 (2024).","DOI":"10.1080\/15548627.2024.2425594"},{"key":"10798_CR28","doi-asserted-by":"publisher","unstructured":"Xiong, Z. et al. MANF facilitates breast cancer cell survival under glucose-starvation conditions via PRKN-mediated mitophagy regulation. Autophagy 1\u201322. https:\/\/doi.org\/10.1080\/15548627.2024.2392415 (2024).","DOI":"10.1080\/15548627.2024.2392415"},{"key":"10798_CR29","doi-asserted-by":"publisher","first-page":"217192","DOI":"10.1016\/j.canlet.2024.217192","volume":"602","author":"H Wu","year":"2024","unstructured":"Wu, H. et al. Blockade of the lncRNA-PART1-PHB2 axis confers resistance to PARP inhibitor and promotes cellular senescence in ovarian cancer. Cancer Lett. 602, 217192. https:\/\/doi.org\/10.1016\/j.canlet.2024.217192 (2024).","journal-title":"Cancer Lett."},{"key":"10798_CR30","doi-asserted-by":"publisher","first-page":"216802","DOI":"10.1016\/j.canlet.2024.216802","volume":"588","author":"H Zhang","year":"2024","unstructured":"Zhang, H. et al. Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma. Cancer Lett. 588, 216802. https:\/\/doi.org\/10.1016\/j.canlet.2024.216802 (2024).","journal-title":"Cancer Lett."},{"key":"10798_CR31","doi-asserted-by":"publisher","first-page":"e35305","DOI":"10.1016\/j.heliyon.2024.e35305","volume":"10","author":"WS Liu","year":"2024","unstructured":"Liu, W. S., Li, R. M., Le, Y. H. & Zhu, Z. L. Construction of a mitophagy-related prognostic signature for predicting prognosis and tumor microenvironment in lung adenocarcinoma. Heliyon 10, e35305. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e35305 (2024).","journal-title":"Heliyon"},{"key":"10798_CR32","doi-asserted-by":"publisher","first-page":"1117297","DOI":"10.3389\/fimmu.2023.1117297","volume":"14","author":"RY Chen","year":"2023","unstructured":"Chen, R. Y. et al. Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury. Front. Immunol. 14, 1117297. https:\/\/doi.org\/10.3389\/fimmu.2023.1117297 (2023).","journal-title":"Front. Immunol."},{"key":"10798_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.21037\/tcr-23-785","volume":"13","author":"Q Ke","year":"2024","unstructured":"Ke, Q. et al. Identification and validation of mitophagy-related signatures as a novel prognostic model for colorectal cancer. Transl Cancer Res. 13, 782\u2013797. https:\/\/doi.org\/10.21037\/tcr-23-785 (2024).","journal-title":"Transl Cancer Res."},{"key":"10798_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s12967-023-04845-6","volume":"22","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. MTFR2-dependent mitochondrial fission promotes HCC progression. J. Transl Med. 22, 73. https:\/\/doi.org\/10.1186\/s12967-023-04845-6 (2024).","journal-title":"J. Transl Med."},{"key":"10798_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1049\/syb2.12035","volume":"15","author":"G Cai","year":"2021","unstructured":"Cai, G., Sun, M., Li, X. & Zhu, J. Construction and characterization of rectal cancer-related lncRNA-mRNA CeRNA network reveals prognostic biomarkers in rectal cancer. IET Syst. Biol. 15, 192\u2013204. https:\/\/doi.org\/10.1049\/syb2.12035 (2021).","journal-title":"IET Syst. Biol."},{"key":"10798_CR36","doi-asserted-by":"publisher","first-page":"108429","DOI":"10.1016\/j.isci.2023.108429","volume":"26","author":"Y Quan","year":"2023","unstructured":"Quan, Y., Zhang, H., Wang, M. & Ping, H. Visium Spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer. iScience 26, 108429. https:\/\/doi.org\/10.1016\/j.isci.2023.108429 (2023).","journal-title":"iScience"},{"key":"10798_CR37","doi-asserted-by":"publisher","first-page":"1424197","DOI":"10.3389\/fimmu.2024.1424197","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang, Y. et al. FAM20A: a potential diagnostic biomarker for lung squamous cell carcinoma. Front. Immunol. 15, 1424197. https:\/\/doi.org\/10.3389\/fimmu.2024.1424197 (2024).","journal-title":"Front. Immunol."},{"key":"10798_CR38","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cell.2015.01.004","volume":"160","author":"E Bonavita","year":"2015","unstructured":"Bonavita, E. et al. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer. Cell 160, 700\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2015.01.004 (2015).","journal-title":"Cell"},{"key":"10798_CR39","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/ibd\/izaa354","volume":"27","author":"X Su","year":"2021","unstructured":"Su, X. et al. LRRC19 promotes permeability of the gut epithelial barrier through degrading PKC-\u03b6 and PKC\u03b9\/\u03bb to reduce expression of ZO1, ZO3, and occludin. Inflamm. Bowel Dis. 27, 1302\u20131315. https:\/\/doi.org\/10.1093\/ibd\/izaa354 (2021).","journal-title":"Inflamm. Bowel Dis."},{"key":"10798_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris, M. A. et al. Towards targeting the breast cancer immune microenvironment. Nat. Rev. Cancer. 24, 554\u2013577. https:\/\/doi.org\/10.1038\/s41568-024-00714-6 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"10798_CR41","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1039\/d2cs00968d","volume":"53","author":"Y Pan","year":"2024","unstructured":"Pan, Y. et al. Immunological nanomaterials to combat cancer metastasis. Chem. Soc. Rev. 53, 6399\u20136444. https:\/\/doi.org\/10.1039\/d2cs00968d (2024).","journal-title":"Chem. Soc. Rev."},{"key":"10798_CR42","doi-asserted-by":"publisher","first-page":"e2142","DOI":"10.1002\/biof.2142","volume":"51","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. Navigating the immune landscape with plasma cells: A pan-cancer signature for precision immunotherapy. Biofactors 51, e2142. https:\/\/doi.org\/10.1002\/biof.2142 (2025).","journal-title":"Biofactors"},{"key":"10798_CR43","doi-asserted-by":"publisher","first-page":"e70011","DOI":"10.1002\/imt2.70011","volume":"4","author":"B Ye","year":"2025","unstructured":"Ye, B. et al. iMLGAM: integrated machine learning and genetic Algorithm-driven multiomics analysis for pan-cancer immunotherapy response prediction. Imeta 4, e70011. https:\/\/doi.org\/10.1002\/imt2.70011 (2025).","journal-title":"Imeta"},{"key":"10798_CR44","doi-asserted-by":"publisher","first-page":"101865","DOI":"10.1016\/j.tranon.2023.101865","volume":"40","author":"W Sun","year":"2024","unstructured":"Sun, W. et al. Systemic immune-inflammation index predicts survival in patients with resected lung invasive mucinous adenocarcinoma. Transl Oncol. 40, 101865. https:\/\/doi.org\/10.1016\/j.tranon.2023.101865 (2024).","journal-title":"Transl Oncol."},{"key":"10798_CR45","doi-asserted-by":"publisher","unstructured":"Denk, D. et al. Expansion of T memory stem cells with superior anti-tumor immunity by Urolithin A-induced mitophagy. Immunity 55, 2059\u20132073. e2058. https:\/\/doi.org\/10.1016\/j.immuni.2022.09.014 (2022).","DOI":"10.1016\/j.immuni.2022.09.014"},{"key":"10798_CR46","doi-asserted-by":"publisher","first-page":"217759","DOI":"10.1016\/j.canlet.2025.217759","volume":"625","author":"M Ma","year":"2025","unstructured":"Ma, M. et al. Sonrotoclax (BGB-11417) synergistically amplifies the radiotherapy-elicited anti-tumor immune response. Cancer Lett. 625, 217759. https:\/\/doi.org\/10.1016\/j.canlet.2025.217759 (2025).","journal-title":"Cancer Lett."},{"key":"10798_CR47","doi-asserted-by":"publisher","first-page":"943090","DOI":"10.3389\/fimmu.2022.943090","volume":"13","author":"K Ding","year":"2022","unstructured":"Ding, K. et al. A score of DNA damage repair pathway with the predictive ability for chemotherapy and immunotherapy is strongly associated with immune signaling pathway in pan-cancer. Front. Immunol. 13, 943090. https:\/\/doi.org\/10.3389\/fimmu.2022.943090 (2022).","journal-title":"Front. Immunol."},{"key":"10798_CR48","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1146\/annurev-immunol-101819-024752","volume":"42","author":"HN Bell","year":"2024","unstructured":"Bell, H. N. & Zou, W. Beyond the barrier: unraveling the mechanisms of immunotherapy resistance. Annu. Rev. Immunol. 42, 521\u2013550. https:\/\/doi.org\/10.1146\/annurev-immunol-101819-024752 (2024).","journal-title":"Annu. Rev. Immunol."},{"key":"10798_CR49","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41573-022-00393-8","volume":"21","author":"AJ Korman","year":"2022","unstructured":"Korman, A. J., Garrett-Thomson, S. C. & Lonberg, N. Author correction: the foundations of immune checkpoint Blockade and the ipilimumab approval decennial. Nat. Rev. Drug Discov. 21, 163. https:\/\/doi.org\/10.1038\/s41573-022-00393-8 (2022).","journal-title":"Nat. Rev. Drug Discov"},{"key":"10798_CR50","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/s41573-021-00345-8","volume":"21","author":"AJ Korman","year":"2022","unstructured":"Korman, A. J., Garrett-Thomson, S. C. & Lonberg, N. The foundations of immune checkpoint Blockade and the ipilimumab approval decennial. Nat. Rev. Drug Discov. 21, 509\u2013528. https:\/\/doi.org\/10.1038\/s41573-021-00345-8 (2022).","journal-title":"Nat. Rev. Drug Discov"},{"key":"10798_CR51","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.eururo.2019.05.041","volume":"76","author":"MO Grimm","year":"2019","unstructured":"Grimm, M. O. et al. Safe use of immune checkpoint inhibitors in the multidisciplinary management of urological cancer: the European association of urology position in 2019. Eur. Urol. 76, 368\u2013380. https:\/\/doi.org\/10.1016\/j.eururo.2019.05.041 (2019).","journal-title":"Eur. Urol."},{"key":"10798_CR52","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3322\/caac.21785","volume":"73","author":"Z Megyesfalvi","year":"2023","unstructured":"Megyesfalvi, Z. et al. Clinical insights into small cell lung cancer: tumor heterogeneity, diagnosis, therapy, and future directions. CA Cancer J. Clin. 73, 620\u2013652. https:\/\/doi.org\/10.3322\/caac.21785 (2023).","journal-title":"CA Cancer J. Clin."},{"key":"10798_CR53","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.eururo.2011.06.047","volume":"60","author":"F Algaba","year":"2011","unstructured":"Algaba, F. et al. Current pathology keys of renal cell carcinoma. Eur. Urol. 60, 634\u2013643. https:\/\/doi.org\/10.1016\/j.eururo.2011.06.047 (2011).","journal-title":"Eur. Urol."},{"key":"10798_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1385\/CRIAI:30:1","volume":"30","author":"A Hennino","year":"2006","unstructured":"Hennino, A. et al. Pathophysiology of urticaria. Clin. Rev. Allergy Immunol. 30, 3\u201311. https:\/\/doi.org\/10.1385\/CRIAI:30:1 (2006).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10798_CR55","doi-asserted-by":"publisher","unstructured":"Meylan, M. et al. Tertiary lymphoid structures generate and propagate anti-tumor antibody-producing plasma cells in renal cell cancer. Immunity 55, 527\u2013541 e525, https:\/\/doi.org\/10.1016\/j.immuni.2022.02.001 (2022).","DOI":"10.1016\/j.immuni.2022.02.001"},{"key":"10798_CR56","doi-asserted-by":"publisher","unstructured":"Fa\u2019ak, F. et al. Selective immune suppression using interleukin-6 receptor inhibitors for management of immune-related adverse events. J. Immunother Cancer. 11 https:\/\/doi.org\/10.1136\/jitc-2023-006814 (2023).","DOI":"10.1136\/jitc-2023-006814"},{"key":"10798_CR57","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53, D672\u2013D677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucleic Acids Res."},{"key":"10798_CR58","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"10798_CR59","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10798-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10798-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10798-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T01:02:06Z","timestamp":1753923726000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-10798-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,26]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["10798"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-10798-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2025,7,26]]},"assertion":[{"value":"27 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The data used in this study were sourced from public databases and local ethics approval was obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agree the publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"27273"}}